Biomolecular condensates as organizers of mRNA decay in bacteria

生物分子凝聚体作为细菌 mRNA 衰变的组织者

基本信息

项目摘要

Despite the absence of organelles, bacteria exhibit an intricate subcellular organization that is required for cells to grow, divide and replicate. A key question is how do simple bacteria go beyond bags of molecules to spatially and temporally organize physiological processes needed to sustain life and regulate development? It has been shown that bacteria achieve subcellular organization using microcompartments, curvature sensing, nucleoid occlusion, and unique lipid and peptidoglycan composition at the cell poles. Liquid-phase separated droplets, termed biomolecular condensates, spatially organize biochemical pathways as membraneless organelles in eukaryotes including P-bodies and stress granules. In collaboration with Jared Schrader's lab, we discovered that ribonuclease Rnase E forms liquid-phase separated bacterial ribonucleoprotein bodies (BR-bodies) that share similarities with P-bodies and stress granules. In this proposal we investigate: 1) the mechanisms that promote Rnase E BR-body formation, 2) mechanisms that regulate selective permeability of BR-bodies to messenger RNA over non-coding RNAs, and 3) the role of Rnase E scaffolding and biomolecular condensation upon mRNA decay. Our studies of BR-bodies will likely provide an illuminating initial example of biomolecular condensates as central organizers of biochemistry within bacteria, and reveal new modes of genetic regulation. This new understanding of mRNA decay should also reveal new insights into regulatory processes that govern bacterial virulence pathways and identify potential antibiotic strategies that disrupt BR-body functions.
尽管没有细胞器,细菌却表现出复杂的亚细胞组织 这是细胞生长、分裂和复制所必需的。一个关键问题是简单细菌如何 超越分子袋,在空间和时间上组织生理过程 需要维持生命和调节发展吗?研究表明,细菌能够达到 使用微区室、曲率传感、类核闭塞等进行亚细胞组织 细胞两极独特的脂质和肽聚糖成分。液相分离的液滴, 称为生物分子凝聚物,在空间上将生化途径组织为无膜 真核生物中的细胞器,包括 P 体和应激颗粒。与贾里德合作 Schrader的实验室,我们发现核糖核酸酶Rnase E形成液相分离 与 P 体和应激具有相似性的细菌核糖核蛋白体(BR 体) 颗粒。在本提案中,我们研究:1) 促进 Rnase E BR-body 的机制 形成,2) 调节 BR 体对信使 RNA 选择性渗透的机制 相对于非编码 RNA,以及 3) Rnase E 支架和生物分子缩合的作用 mRNA 衰变时。我们对 BR 体的研究可能会提供一个具有启发性的初步例子 生物分子凝聚体作为细菌内生物化学的中心组织者,并揭示了新的 遗传调控模式。对 mRNA 衰变的新认识也应该揭示新的 深入了解控制细菌毒力途径的监管过程并识别潜在的 破坏 BR 体功能的抗生素策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Seth Childers其他文献

William Seth Childers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Seth Childers', 18)}}的其他基金

Biomolecular condensates as organizers of mRNA decay in bacteria
生物分子凝聚体作为细菌 mRNA 衰变的组织者
  • 批准号:
    10376044
  • 财政年份:
    2020
  • 资助金额:
    $ 30.78万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 30.78万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 30.78万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 30.78万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 30.78万
  • 项目类别:
    Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 30.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了